What is your approach to re-challenging BTK inhibitors for a patient who has had intolerance to several different agents?
1 Answers
Mednet Member
Medical Oncology · Ohio State University
This is a great question, and the answer is that I probably would not rechallenge with a BTK inhibitor. Many patients who develop an intolerance to a BTKi can remain on the drug with supportive care for the toxicity and/or dose reduction, which is not always effective. If someone truly had an intole...